Gunter et al. [103] conducted a retrospective analysis involving 875 postmenopausal breast cancer patients and 839 volunteers and found significantly reduced levels of adiponectin in the blood of breast cancer patients, concurrent with a decrease in adiponectin levels in CAAs [104,105]. The gene discussed is ADIPOQ; the disease is breast carcinoma.